Castle Biosciences, Inc. today announced the appointment of Mara G. Aspinall to its Board of Directors, and the addition of James L. Dunn, Jr. to its senior leadership team.
Mara Aspinall most recently served as President and Chief Executive Officer of the Roche Group’s Ventana Medical Systems, a global leader in tissue-based cancer diagnostics. She previously spent 12 years with Genzyme Corporation as President of Genzyme Genetics and President of Genzyme Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
